indazoles has been researched along with Liposarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blay, JY | 1 |
| Chawla, SP; Kaiser, PE; Milhem, MM; Portnoy, DC; Priebat, DA; Samuels, BL; Skubitz, KM; Somaiah, N; Staddon, AP; Stepanski, EJ; Walker, MS | 1 |
| Gilbert, JA | 1 |
| Asai, T; Horie, S; Ichiyanagi, O; Kabasawa, T; Kato, T; Nishida, H; Sakurai, T; Tsuchiya, N; Yagi, M | 1 |
| Dry, SM; Eilber, FC; Hoffman, RM; Igarashi, K; Kanaya, F; Kawaguchi, K; Kiyuna, T; Li, Y; Miyake, K; Miyake, M; Murakami, T; Nelson, SD; Russell, TA; Singh, AS; Singh, SR; Tome, Y | 1 |
| Grad, I; Han, J; Hanes, R; Karlsen, I; McCormack, E; Meza-Zepeda, LA; Munthe, E; Myklebost, O; Stratford, EW | 1 |
| Barangi, M; Bouvet, M; Chawla, SP; Endo, I; Higuchi, T; Hiroshima, Y; Hoffman, RM; Homma, Y; Katsuya, Y; Li, Y; Matsuyama, R; Miyake, K; Murakami, T; Nelson, SD; Oshiro, H; Park, JH; Razmjooei, S; Singh, SR; Sugisawa, N; Zhang, Z | 1 |
| Akihama, S; Habuchi, T; Inoue, T; Koizumi, A; Narita, S; Numakura, K; Saito, M; Satoh, S; Takahashi, M; Takayama, K; Tsuchiya, N; Tsuruta, H | 1 |
| Araki, N; Boku, S; Goto, T; Hiraga, H; Honoki, K; Kawai, A; Matsumine, A; Nakamura, T; Nishida, Y; Sudo, A; Sugiura, H; Ueda, T; Yasuda, T; Yonemoto, T | 1 |
| Kishikawa, H; Nakagawa, M; Nakazawa, S; Nishimura, K; Sekii, Y; Yoshinaga, M | 1 |
1 review(s) available for indazoles and Liposarcoma
| Article | Year |
|---|---|
[Recurrence of Well Differentiated Intrascrotal Liposarcoma in Retroperitoneum Five Years after Resection : A Case Report].
Topics: Aged; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Humans; Indazoles; Liposarcoma; Male; Orchiectomy; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed | 2017 |
1 trial(s) available for indazoles and Liposarcoma
| Article | Year |
|---|---|
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Follow-Up Studies; Humans; Indazoles; Liposarcoma; Male; Middle Aged; Neoplasm Grading; Prospective Studies; Pyrimidines; Sulfonamides; Survival Rate; Young Adult | 2017 |
8 other study(ies) available for indazoles and Liposarcoma
| Article | Year |
|---|---|
Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Female; Furans; Gemcitabine; Humans; Ifosfamide; Indazoles; Ketones; Liposarcoma; Middle Aged; Prognosis; Pyrimidines; Sulfonamides; Survival Rate; Trabectedin | 2019 |
Pazopanib for advanced liposarcoma.
Topics: Antineoplastic Agents; Clinical Trials, Phase II as Topic; Disease Progression; Disease-Free Survival; Humans; Indazoles; Liposarcoma; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome | 2017 |
Pazopanib-induced crystal deposition in intestinal mucosa in a patient with retroperitoneal liposarcoma.
Topics: Adult; Antineoplastic Agents; Edema; Endoscopy, Gastrointestinal; Humans; Indazoles; Intestinal Diseases; Intestinal Mucosa; Kidney Neoplasms; Liposarcoma; Male; Neoplasm Recurrence, Local; Pyrimidines; Retroperitoneal Neoplasms; Sulfonamides; Tomography, X-Ray Computed | 2018 |
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.
Topics: Aged; Animals; Doxorubicin; Gene Amplification; Humans; Indazoles; Liposarcoma; Male; Mice; Mice, Nude; Neoplasm Proteins; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sulfonamides; Xenograft Model Antitumor Assays | 2018 |
Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Gene Amplification; Humans; Indazoles; Liposarcoma; MAP Kinase Signaling System; Membrane Proteins; Mice; Phenylurea Compounds; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Treatment Outcome | 2019 |
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Models, Animal; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Gemcitabine; Heterografts; Humans; Indazoles; Liposarcoma; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Pyrimidines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
[Pazopanib for three patients with recurrence of retroperitoneal liposarcoma : initial clinical experience].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Humans; Indazoles; Liposarcoma; Male; Middle Aged; Neoplasm Staging; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Tomography, X-Ray Computed | 2015 |
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Female; Fibrosarcoma; Humans; Hypertension; Indazoles; Japan; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Pneumothorax; Product Surveillance, Postmarketing; Pyrimidines; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Sulfonamides; Survival Analysis; Thrombocytopenia | 2016 |